- Home
- STEP vs APGE Comparison
STEP vs APGE Comparison
Compare STEP & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STEP | APGE |
|---|---|---|
| Founded | 2007 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 4.7B |
| IPO Year | 2020 | 2023 |
Fundamental Metrics
Financial Performance| Metric | STEP | APGE |
|---|---|---|
| Price | $42.86 | $69.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | $80.71 | ★ $103.33 |
| AVG Volume (30 Days) | ★ 1.5M | 815.9K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.23% | N/A |
| EPS Growth | N/A | ★ 1.79 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,174,830,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $32.34 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 65.09 | N/A |
| 52 Week Low | $40.27 | $26.20 |
| 52 Week High | $77.80 | $84.56 |
Technical Indicators
Market Signals| Indicator | STEP | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 23.13 | 49.23 |
| Support Level | N/A | $35.24 |
| Resistance Level | $64.38 | $71.18 |
| Average True Range (ATR) | 3.32 | 3.42 |
| MACD | -1.32 | 0.61 |
| Stochastic Oscillator | 1.86 | 68.94 |
Price Performance
Historical ComparisonAbout STEP StepStone Group Inc.
StepStone Group Inc operates as a fully integrated private markets solution provider. The company provides customized investment solutions and advisory and data services. It provides investment solutions in the areas of private equity, real estate, private debt, and infrastructure and real assets. The company consists of a single operating segment and a single reportable segment for accounting and financial reporting purposes.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.